BELITE BIO, INC (BLTE)

Every FINRA and SEC series the site collects for BELITE BIO, INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

1.1M

Short interest

settlement 2026-08-14

5.8

Days to cover

-1.6% vs prior

59.5%

Short share of volume

2026-09-11

Fails to deliver

settlement 2026-08-05

-$33.3M

Insider flow, 90 days

0 buys, 52 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 14 August 2026, short interest in BLTE is 1,116,380 shares, down 198,690 shares over the last month. Over the last 48 readings it ranged from 60,691 shares (15 April 2025) to 1,324,951 shares (15 June 2026). At the reported average volume of 191K shares a day that is 5.8 days to cover, elevated.

Embed this chartfree, with the attribution line it carries

<iframe src="https://xoomar.com/embed/stocks/blte" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-08-14	1,116,380	-1.6%	191,273	5.84
2026-07-31	1,134,633	-13.7%	168,803	6.72
2026-07-15	1,315,070	+0.1%	186,330	7.06
2026-06-30	1,314,142	-0.8%	247,077	5.32
2026-06-15	1,324,951	+10.3%	238,100	5.56
2026-05-29	1,201,317	+0.9%	242,599	4.95
2026-05-15	1,191,024	-3.4%	122,831	9.70
2026-04-30	1,233,097	+10.6%	109,295	11.28
2026-04-15	1,114,481	+6.7%	159,060	7.01
2026-03-31	1,044,796	+5.5%	173,982	6.01
2026-03-13	990,833	+25.1%	187,136	5.29
2026-02-27	792,323	+16.2%	155,304	5.10
2026-02-13	681,671	+16.5%	209,155	3.26
2026-01-30	585,301	+49.4%	208,978	2.80
2026-01-15	391,677	+18.8%	290,705	1.35
2025-12-31	329,748	+12.1%	204,995	1.61
2025-12-15	294,199	-45.3%	362,897	1.00
2025-11-28	537,302	+85.1%	195,692	2.75
2025-11-14	290,232	+6.3%	103,831	2.80
2025-10-31	272,936	+16.6%	90,888	3.00
2025-10-15	234,030	-0.5%	60,731	3.85
2025-09-30	235,117	+18.8%	54,746	4.29
2025-09-15	197,932	+9.8%	46,114	4.29
2025-08-29	180,333	-4.6%	35,549	5.07

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of BLTE volume is 59.5%, up 5.0 points over the last five sessions. Over the last 52 readings it ranged from 31.0% (28 July 2026) to 77.8% (30 June 2026). The latest reading is 2.5 points above the 30-session average of 57.0%, on 54K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-09-11	32K	54K	59.5%	0
2026-09-10	57K	83K	68.9%	3,111
2026-09-09	57K	94K	60.9%	5
2026-09-08	179K	284K	63.1%	24,644
2026-09-04	210K	363K	57.8%	55,753
2026-09-03	62K	114K	54.4%	0
2026-09-02	76K	107K	71.5%	0
2026-09-01	34K	51K	67.3%	0
2026-08-31	39K	62K	62.7%	0
2026-08-28	37K	57K	65.4%	0
2026-08-27	33K	47K	71.1%	0
2026-08-26	75K	96K	77.8%	0
2026-08-25	16K	25K	63.6%	0
2026-08-24	40K	57K	70.3%	50
2026-08-21	20K	40K	49.7%	0
2026-08-20	26K	55K	46.7%	0
2026-08-19	29K	57K	50.5%	0
2026-08-18	17K	38K	44.4%	300
2026-08-17	40K	70K	56.6%	3
2026-08-14	47K	83K	57.1%	0
2026-08-13	114K	265K	43.1%	0
2026-08-12	29K	70K	41.8%	163
2026-08-11	53K	112K	47.1%	0
2026-08-10	20K	46K	44.1%	0
2026-08-07	22K	43K	50.7%	0
2026-08-06	20K	51K	39.0%	32
2026-08-05	15K	28K	51.7%	0
2026-08-04	20K	40K	50.1%	0
2026-08-03	48K	80K	60.9%	0
2026-07-31	40K	63K	62.9%	50

Fails to deliver

SEC, by settlement date. JSON

As of 5 August 2026, the fails-to-deliver balance in BLTE is 51 shares, up 24 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (17 February 2026) to 65,732 shares (26 November 2025). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-08-05	51	$157.27	$8K
2026-07-31	27	$159.92	$4K
2026-07-29	48	$155.95	$7K
2026-07-27	1,303	$153.36	$200K
2026-07-20	82	$150.08	$12K
2026-07-17	47	$150.67	$7K
2026-06-30	1	$154.65	$155
2026-06-03	10,209	$134.93	$1.4M
2026-06-02	444	$147.00	$65K
2026-04-16	500	$168.76	$84K
2026-04-08	5	$169.79	$849
2026-04-02	540	$167.25	$90K
2026-03-26	879	$155.04	$136K
2026-03-25	869	$150.83	$131K
2026-03-19	371	$161.34	$60K
2026-03-18	253	$161.41	$41K
2026-03-16	261	$164.11	$43K
2026-03-13	371	$169.55	$63K
2026-03-10	1,360	$179.12	$244K
2026-03-06	109	$172.57	$19K
2026-03-05	4,392	$177.79	$781K
2026-03-04	18,703	$167.88	$3.1M
2026-03-03	4,099	$177.58	$728K
2026-03-02	238	$190.30	$45K
2026-02-27	373	$188.55	$70K
2026-02-17	1	$175.26	$175
2026-02-09	2	$187.86	$376
2026-01-26	6,935	$164.58	$1.1M
2026-01-12	1,665	$158.36	$264K
2026-01-05	65	$159.27	$10K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at BLTE reported 52 open-market sells worth $33.3M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Lin Yu-Hsin (Chief Executive Officer) on 2026-09-08.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	Sell	3K	$198.09	$535K	70K
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	Sell	9K	$197.36	$1.7M	73K
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	Sell	6K	$196.54	$1.2M	82K
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	Sell	6K	$195.62	$1.2M	88K
2026-09-08	Lin Yu-Hsin	Chief Executive Officer	Sell	2K	$194.33	$466K	94K
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	Sell	3K	$198.05	$507K	26K
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	Sell	5K	$197.23	$908K	29K
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	Sell	4K	$196.47	$879K	33K
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	Sell	4K	$195.60	$806K	38K
2026-09-08	Chuang Hao-Yuan	Chief Financial Officer	Sell	2K	$194.28	$427K	42K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	8K	$193.13	$1.6M	96K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	4K	$192.54	$810K	104K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	11K	$191.15	$2.1M	108K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	600	$190.39	$114K	120K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	9K	$189.34	$1.7M	120K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	3K	$188.26	$573K	129K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	6K	$187.25	$1.2M	132K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	8K	$186.32	$1.5M	138K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	5K	$185.34	$851K	146K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	6K	$184.52	$1.2M	151K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	5K	$183.30	$908K	157K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	3K	$182.50	$623K	162K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	3K	$181.24	$469K	165K
2026-09-04	Lin Yu-Hsin	Chief Executive Officer	Sell	3K	$180.29	$475K	168K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	5K	$193.12	$889K	44K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	3K	$192.40	$654K	49K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	2K	$190.63	$343K	58K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	6K	$189.22	$1.2M	60K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	2K	$188.59	$358K	66K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	4K	$187.16	$730K	68K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	5K	$186.34	$857K	72K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	4K	$185.28	$717K	77K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	4K	$184.57	$659K	80K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	4K	$183.27	$689K	84K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	2K	$181.05	$362K	90K
2026-09-04	Chuang Hao-Yuan	Chief Financial Officer	Sell	2K	$180.16	$294K	92K
2026-08-12	Chuang Hao-Yuan	Chief Financial Officer	Sell	223	$180.57	$40K	93K
2026-08-12	Chuang Hao-Yuan	Chief Financial Officer	Sell	144	$180.00	$26K	94K
2026-08-12	Lin Yu-Hsin	Chief Executive Officer	Sell	223	$180.57	$40K	171K
2026-08-12	Lin Yu-Hsin	Chief Executive Officer	Sell	142	$180.00	$26K	171K
2026-06-18	Scholl Hendrik Peter	Chief Medical Officer	Sell	1K	$146.24	$175K	15K
2026-06-18	Scholl Hendrik Peter	Chief Medical Officer	Sell	5K	$145.43	$707K	16K
2026-06-18	Scholl Hendrik Peter	Chief Medical Officer	Sell	4K	$144.66	$542K	21K
2026-06-18	Scholl Hendrik Peter	Chief Medical Officer	Sell	96	$143.90	$14K	25K
2026-06-16	Scholl Hendrik Peter	Chief Medical Officer	Sell	1K	$145.02	$150K	25K
2026-06-16	Scholl Hendrik Peter	Chief Medical Officer	Sell	2K	$143.55	$272K	26K
2026-06-16	Scholl Hendrik Peter	Chief Medical Officer	Sell	450	$142.20	$64K	28K
2026-06-16	Scholl Hendrik Peter	Chief Medical Officer	Sell	100	$141.83	$14K	28K
2026-06-16	Scholl Hendrik Peter	Chief Medical Officer	Sell	540	$140.58	$76K	28K
2026-06-16	Scholl Hendrik Peter	Chief Medical Officer	Sell	3K	$139.57	$438K	29K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

13F holders

Tracked managers holding BLTE at their latest 13F. JSON

6 of the 30 tracked managers held BLTE at their latest 13F, $143.5M in total at quarter-end prices. Millennium Management is the largest at $76.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Millennium Management	2026-06-30	495K	$76.2M	0.03%	-76K
Citadel Advisors	2026-06-30	186K	$28.7M	0.00%	+184K
Duquesne Family Office	2026-06-30	106K	$16.3M	0.31%	0
Renaissance Technologies	2026-06-30	56K	$8.6M	0.01%	+4K
Point72 Asset Management	2026-06-30	51K	$7.9M	0.01%	-233K
Two Sigma Investments	2026-06-30	38K	$5.9M	0.00%	new or n/a

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

BELITE BIO, INC in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows BELITE BIO, INC (BLTE), SEC CIK 1889109, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest: FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-05.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Insider trades: SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-08.JSON and CSV
Company record: EDGAR filing index for CIK 1889109Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of BLTE is sold short?

1,116,380 shares were held short at the 2026-08-14 settlement, 5.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is BLTE's daily short volume?

On 2026-09-11, 32,340 of the 54,380 BLTE shares reported to FINRA were sold short, 59.5% of the day's reported volume. Short volume is a flow for one day, not a position.

Does BLTE have fails to deliver?

The SEC's latest file shows 51 BLTE shares failed to deliver at settlement 2026-08-05. Fails are reported per settlement date and published twice a month with a lag.

Are BLTE insiders buying or selling?

Which funds hold BLTE?

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

BELITE BIO, INC (BLTE)

Short interest

Daily short volume

Fails to deliver

Insider trades

13F holders

BELITE BIO, INC in the regulatory record

Source and method

How to read it

Other companies the SEC classifies as pharmaceutical preparations

Datasets

Frequently Asked Questions